$VRTX news
The latest VRTX stock news: headlines, filings, AI summaries and sentiment for $VRTX, updated around the clock.
- Major US Indexes and Biotech Sector Rally Following Election and Strong Earnings
- Alkermes Reports Q3 2026 Results with Strong Proprietary Product Growth
- VERTEX PHARMACEUTICALS INC / MA - 10-Q Filing
- Vertex Raises 2026 Revenue Guidance Amid Portfolio Diversification
- Apple Reports Record Fourth Quarter Revenue Amid Rising Memory Chip Costs
- Vertex Pharmaceuticals Reports Q3 2026 Revenue Growth and Raises Full-Year Guidance
- Vertex Pharmaceuticals Issues 2026 Revenue Guidance of $13.15B-$13.25B
- Vertex Pharmaceuticals Raises 2026 Revenue Guidance Following Q3 Results
- Vertex Pharmaceuticals Reports 12% Revenue Growth Driven by Alyftrek Transition
- CRISPR Therapeutics Reports $99 Million in Casgevy Sales Amid Widening Net Loss
- Vertex Pharmaceuticals Reports Q3 Revenue Beat Amid Slight EPS Miss
- VERTEX PHARMACEUTICALS INC / MA - 8-K Filing
- Krystal Biotech Reports Q3 2026 Results with $127.3 Million VYJUVEK Revenue
- Vertex Pharmaceuticals Scheduled to Report Q3 2026 Earnings
- Insmed Reports Q3 2026 Revenue Growth of 268% Driven by BRINSUPRI Launch
- Amgen vs. Vertex Pharmaceuticals: A Comparison of Revenue Scale and Growth Trajectories
- VERTEX PHARMACEUTICALS INC / MA - 8-K Filing
- Cathie Wood Increases Stake in CRISPR Therapeutics Amid Strategic Developments
- Cystic Fibrosis: The Remaining 10% Still Lack Effective Treatments
- BMO Upgrades Vertiv to Outperform With a Price Target of $329
- Vertex Pharmaceuticals Expands Beyond Cystic Fibrosis at Cantor Conference
- Vertex Acquires Crinetics in $10 Billion Deal for Expansion into Endocrinology
- Vertex Pharmaceuticals Reports Strong Q2 Results, Raises Guidance
- Vertiv's Acquisition of Utility Innovation Holdings Bolsters AI Data Center Dominance
- Vertex Pharmaceuticals Stock Rises After J.P. Morgan Upgrades Rating
- CRISPR Therapeutics Shares Rise Nearly 19% in August on Strong Earnings and Business Update
- Greg Abel of Berkshire Hathaway Flags Growing Resistance to Data Centers Amid Political Shifts
- Vertiv Acquires Utility Innovations for Up to $2.6 Billion to Address Power Bottlenecks in AI Data Centers
- Fundstrat Capital Completes August 2026 Rebalance for Granny Shots ETFs
- Premarket Stock Movements: Vertiv, Sirius, Dell and Others
- VERTEX PHARMACEUTICALS INC / MA - 8-K Filing
- Vertiv's Stock Surge Was Driven By Order Growth and Margin Recovery
- $3 Trillion in Off-Balance-Sheet AI Commitments Reported by Wall Street Journal Affect Vertiv and GE Vernova
- Stocks That Historically Move With or Against Nvidia Earnings
- Vertiv Reports Strong Q2 Results and Raises Full-Year Outlook
- Vertex Acquires Crinetics for $10 Billion; Viking Therapeutics Seen as Potential Next Target
- Vertiv's Q2 Sales Miss Guidance, Leading to Sharp Share Decline
- Wall Street Maintains Confidence in Bloom Energy Amid Reddit Sentiment Shift
- Vertiv CEO Addresses Stock Plunge Amid Disappointing Quarter
- Vertiv Raises Full-Year Outlook for 2026 with Strong Financial Performance
- Vertiv Shares Drop Over 16% After Mixed Q2 Earnings Report
- AbCellera Collaborates With Vertex Pharma on Drug Discovery for Autoimmune Diseases
- Vertiv Q2 Earnings Miss Revenue Estimate Despite Stronger-Than-Expected Adjusted EPS
- Vertiv Holdings Shares Drop After Revenue Miss
- Vertiv Reports Q2 Non-GAAP EPS Beat but Revenue Misses Estimates
- Vertiv Stock Surges Over 100% in First Half of 2026
- Vertex Pharmaceuticals Acquires Crinetics in $10 Billion Deal at High Premium
- Pain Drug Developer Latigo Biotherapeutics Plans IPO
- BGL Announces Sale of Strategic Thermal Labs to Vertiv
- Vertex Pharmaceuticals Acquires Crinetics Pharmaceuticals for $10 Billion